4th Quarter - Report

TARPLIN, DOWNS & YOUNG, LLC for SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION)

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

- orphan drug tax credit H.R. 3678 - Preserving Access to Orphan Drug Act of 2015 S. 1906/H.R. 3618 - Orphan Drug Fairness Act

Foreign entity interest: "As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Form LD-1, has an interest in the issues lobbied."

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
CHARLOTTE SPEARS IVANCIC —
ELIZABETH T MURRAY —
JENNIFER B YOUNG —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 3678 (114th), S. 1906 (114th), H.R. 3618 (114th)

Copyright/Patent/Trademark CPT

H.R. 9 - Innovation Act S. 779 - Fair Access to Science and Technology Research Act of 2015 S. 1137 - PATENT Act

Foreign entity interest: "As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Form LD-1, has an interest in the issues lobbied."

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
CHARLOTTE SPEARS IVANCIC —
ELIZABETH T MURRAY —
JENNIFER B YOUNG —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 1137 (114th), H.R. 9 (114th), S. 779 (114th)

Health Issues HCR

Health care reform, drug importation, 340b, biosimilars PL 111-148 - The Patient Protection and Affordable Care Act, PL 111-152 - The Reconciliation Act of 2010, implementation PL 112-144 - The Food and Drug Administration Safety and Innovation Act, implementation H.R. 6 - 21st Century Cures Innovation For Healthier Americans S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 1878 - Advancing Hope Act S. 2912 - Right to Try Act ***no specific bills, importation, Prescription Drug User Fee Act Renewal and associated policies, supply chain integrity, user fee sequester, Innovation

Foreign entity interest: "As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Form LD-1, has an interest in the issues lobbied."

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
CHARLOTTE SPEARS IVANCIC —
ELIZABETH T MURRAY —
JENNIFER B YOUNG —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 2912 (114th), S. 1878 (114th), S. 2700 (114th), H.R. 6 (114th)

Medicare/Medicaid MMM

PL 111-148 - The Patient Protection and Affordable Care Act, implementation, ESRD, clinical laboratory payment H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 H.R. 1470/S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015 Part B demonstration H.R. 5122 - Part B demonstration H.R. 34 - 21st Century Cures Act ***, no specific bill(s), Medicare Reimbursement, Medicaid Rebate, Medicaid Coverage and Reimbursement, quality indicators, coding, MS, Infusion, oncology, CMMI S. 275/H.R. 609 - Home Infusion Site of Care Act

Foreign entity interest: "As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Form LD-1, has an interest in the issues lobbied."

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte.
MICHELLE P EASTON Chief Health Counsel, Sen. Cmte. on Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst., Congressman Billy Tauzin
CHARLOTTE SPEARS IVANCIC Legislative Counsel, Senator Jim DeMint; Health Counsel, Majority Leader Bill Frist; Counsel and Budget Analyst, House Budget Committee; Asst. to the Speaker for Policy, Speaker John Boehner
ELIZABETH T MURRAY Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham
JENNIFER B YOUNG Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 609 (114th), H.R. 2 (114th), H.R. 5122 (114th), H.R. 1470 (114th), S. 810 (114th), S. 275 (114th), H.R. 34 (114th)

Budget/Appropriations BUD

budget resolution, reconciliation, deficit reduction, debt ceiling, apropriations H. Con. Res. 27 - House budget resolution S. Con. Res. 11 - Senate budget resolution H.R. 1314 - Bipartisan Budget Act of 2015 H.R. 3762 - Restoring Americans' Healthcare Freedom Reconciliation Act of 2015 H.R. 5325 - Continuing Appropriations H.R. 2028 - Further Continuing and Security Assistance Appropriations Act, 2017

Foreign entity interest: "As the ultimate parent of Genzyme Corporation, Sanofi-aventis, identified on Form LD-1, has an interest in the issues lobbied."

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
CHARLOTTE SPEARS IVANCIC —
ELIZABETH T MURRAY —
JENNIFER B YOUNG —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5325 (114th), H.R. 3762 (114th), H.R. 1314 (114th), S.Con.Res. 11 (114th), H.R. 2028 (114th), H.Con.Res. 27 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.